China Post Securities released a research report on April 12 stating that it gave Australian and Chinese endoscopy (688212.SH) a purchase rating. The main reasons for the rating include: 1) The company's main business of endoscopic equipment, diagnostic consumables and maintenance services achieved sales revenue of 677 million yuan during the reporting period, an increase of 52.07% over the same period last year; 2) the company continued to deepen the market coverage depth and breadth of its products, guided by domestic and foreign market needs, and continuously improve its professional academic service capabilities. (Mainichi Keizai Shimbun)